Jiangsu Hengrui reported CNY2.56B in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Kangmei Pharma CNY -12.72M 13.97M Mar/2026
Sh Fosun Pharma CNY 817.9M 46.25M Mar/2026
Sh Pharmaceutical CNY 1.88B 283.52M Dec/2025
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Wuxi Apptec CNY 5.64B 965.29M Mar/2026
Zz Pientze Pharmaceu CNY 837.81M 336.48M Mar/2026